Abstract Submission

SUBMIT YOUR ORIGINAL RESEARCH TO ANR2018 IN SAN FRANCISCO!

 

The scientific organizers welcome the submission of original Neuroblastoma research for presentation at ANR2018 in San Francisco.  The biennial Advances in Neuroblastoma Research Congress is the leading international forum for sharing the most recent advances in basic, translational and clinical Neuroblastoma research.

Below is a list of major topics from previous ANR events. The scientific organizers are currently finalizing the abstract categories for ANR2018, and the submission site will open in the Fall of 2017.

 

Animal Models – Genetically engineered mice, preclinical drug evaluation

Developmental Biology – Neuroblastoma stem cells, embryonic development of the autonomous nervous system, spontaneous regression

Diagnosis and Monitoring Disease – Imaging techniques, risk groups, response criteria, minimal residual disease

Genetics – MYCN, miRNA, ALK, oncogenic pathways, genomic instabilities, therapeutic targets

Pathways – Apoptosis and telomeres, specific pathway interaction, development of metastasis, chromatin modifications and epigenetics

Therapy – Immunotherapy, new therapies in patients, results of clinical trials, radiation therapy, surgical neuroblastoma treatment, trials in countries with limited resources, palliative care, nursing related topics

 

Abstract submission site opens in the Fall of 2017!